Surgical management of acute aortic root endocarditis with viable homograft: 13-year experience
Authors:
- A.C. YankahAYA.C. Yankah
- H. KloseHKH. Klose
- R. PetzinaRPR. Petzina
- M. MusciMMM. Musci
- H. SiniawskiHSH. Siniawski
- R. HetzerRHR. Hetzer
- 1 February 2002
- journal article
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 21 (2) , 260-267
Abstract
Cryopreserved homograft valves have been used for acute infective aortic root endocarditis with great success but it is compounded by its availability in all sizes. The long-term clinical results of geometric mismatched homografts are not well defined and addressed. Over a 15-year period (April 1986-June 2001), 816 patients presented with active infective endocarditis. One hundred and eighty-two of the patients aged between 9 and 78 years (mean: 51.0 +/- 1.13 years) consisting of 142 males and 40 females received homograft aortic valves. One hundred and ten patients were in NYHA functional class III and 72 in class IV and in cardiogenic shock. Of the patients, 2.7% suffered from septic embolism. One hundred and twenty-four (68.1%) patients presented with periannular abscesses and 58 (31.9%) with no abscess while 107 native valve (NVE) and 75 prosthetic valve (PVE) endocarditis were diagnosed preoperatively by transesophageal echocardiography (TEE) and confirmed intraoperatively. Freehand subcoronary implantation (FSCI) was used in 106 patients and root replacement in 76 patients. The operative death was 8.5% and for patients in NYHA functional class IV and in cardiogenic shock was 14.5%. Late mortality rate was 7.9%. Patient survival after discharge from hospital at 1 year was 97% and at 10 years was 91%, respectively. Thirty-one (22.1%) patients underwent reoperation after 1.7 years (mean) with two deaths (6.4%). Early (< or = 60 days) and late reinfection rate was 2.7 and 3.6%, respectively. Freedom from reoperation for matched and undersized homografts at 10-13 years was 85 and 55%, respectively. The univariate model identified undersized homograft (P=0.002), FSCI (P=0.09) and reinfection (P=0.0001) as independent risk factors for developing early and late valve dysfunction resulting in reoperation and homograft explant. Early aggressive valve replacement with homograft for active infective aortic root endocarditis with periannular abscesses is more successful than delayed last resort surgery. Homografts exhibit excellent clinical performance and durability with a low rate of reinfection, if properly inserted. Undersized homograft is an incremental risk factor for early and late reoperation.Keywords
This publication has 18 references indexed in Scilit:
- The use of aortic allografts for surgical management of mycotic infections and aneurysms of the thoracic aorta1997
- Long-term results of valve replacement using antibiotic-sterilised homografts in the aortic positionEuropean Journal of Cardio-Thoracic Surgery, 1996
- Aortic Allograft Valve lmplantation: Freehand or Root Replacement?Journal of Cardiac Surgery, 1994
- New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findingsThe American Journal of Medicine, 1994
- The use of unstented homograft valves for aortic valve reoperationsThe Journal of Thoracic and Cardiovascular Surgery, 1994
- Long-term function of cryopreserved aortic homograftsThe Journal of Thoracic and Cardiovascular Surgery, 1993
- Aortic valve replacement for active infectious endocarditis in 108 patientsThe Journal of Thoracic and Cardiovascular Surgery, 1992
- Prosthetic valve endocarditisThe Journal of Thoracic and Cardiovascular Surgery, 1986
- Antibiotic-resistant Staphylococcus epidermidis in patients undergoing cardiac surgeryAntimicrobial Agents and Chemotherapy, 1980
- Homograft Aortic Valve Replacement in Aortic Incompetence and StenosisThorax, 1964